Iron Deficiency Anemia in Gynecological Cancer Patients
Author Information
Author(s): Muacevic Alexander, Adler John R, Yagi Taro, Kinose Yasuto, Koizumi Mai, Iwamiya Tadashi, Ito Futa, Kubota Satoshi, Sawada Kenjiro, Kimura Tadashi, Takemura Masahiko, Morishige Ken-ichirou
Primary Institution: Osaka General Medical Center and Osaka University
Hypothesis
What is the prevalence of iron deficiency anemia in gynecological cancer patients undergoing treatment?
Conclusion
74% of patients with chemotherapy-induced anemia under gynecologic cancer treatments were found to have iron deficiency anemia.
Supporting Evidence
- 74% of patients with chemotherapy-induced anemia were found to have iron deficiency anemia.
- Anemia negatively affects quality of life and cancer outcomes.
- Only 39% of patients with chemotherapy-induced anemia are treated according to guidelines.
Takeaway
Most patients with cancer who are getting treatment and feel tired might not have enough iron in their blood, which is important for feeling good.
Methodology
Retrospective review of electronic records of patients with gynecological cancer from two hospitals.
Potential Biases
Potential bias due to the small sample size and lack of comprehensive screening for anemia.
Limitations
The small number of participants and heterogeneity of patients' backgrounds may bias the results.
Participant Demographics
Mean age of participants was 64.7 years, with various types of gynecological cancers.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website